Biophytis Delays Release of 2024 Financial Statements

Biophytis SA, a biotechnology firm based in Paris and Cambridge, has announced a delay in the publication of its 2024 annual financial statements. Initially set for April 30, 2025, the release has been pushed back due to a €2.6 million refinancing operation that required significant focus on discussions and negotiations. The company aims to publish the statements by the end of May 2025.

This delay follows the refinancing initiative announced in March 2025, underscoring the company's current focus on strategic financial adjustments. Biophytis is actively working to finalize these statements, ensuring compliance with regulatory requirements while addressing ongoing financial operations.